BGC vs CME

For growth investors, BGC Group, Inc (BGC) is the stronger pick with 27.

6% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 8x trailing P/E (23. 6x forward), making it the more compelling value choice. Analysts rate BGC Group, Inc (BGC) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 8x versus BGC Group, Inc at 35. 1x. On forward P/E, BGC Group, Inc is actually cheaper at 7. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: BGC Group, Inc wins at 0. 25x versus CME Group Inc. 's 1. 72x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, BGC Group, Inc (BGC) delivered a total return of +98.

4%, compared to +64. 1% for CME Group Inc. (CME). Over 10 years, the gap is even starker: CME returned +291. 2% versus BGC's +125. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus BGC Group, Inc's 0. 78β — meaning BGC is approximately -355% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 155% for BGC Group, Inc — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), BGC Group, Inc (BGC) is pulling ahead at 27.

6% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: BGC Group, Inc grew EPS 24. 0% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 5. 5% for BGC Group, Inc — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 16. 8% for BGC. At the gross margin level — before operating expenses — BGC leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, BGC Group, Inc (BGC) is the more undervalued stock at a PEG of 0. 25x versus CME Group Inc. 's 1. 72x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, BGC Group, Inc (BGC) trades at 7. 6x forward P/E versus 23. 6x for CME Group Inc. — 16. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CME: 11. 1% to $320. 25.

In this comparison, CME (3.

8% yield) pays a dividend. BGC does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, CME Group Inc.

(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +291. 2% 10Y return). Both have compounded well over 10 years (CME: +291. 2%, BGC: +125. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BGC is a small-cap high-growth stock; CME is a mid-cap income-oriented stock. CME pays a dividend while BGC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.